Jougla E, Papoz L, Balkau B, Maguin P, Hatton F. Death certificate coding practices related to diabetes in European countries--the “EURODIAB Subarea C” Study. Int J Epidemiol [Internet]. 1992 Apr [cited 2012 Jun 27];21(2):343–5Available from: http://www.ncbi.nlm.nih.gov/pubmed/1428491
Jougla E, Hatton F, Le Toullec A, Michel E. [Trends in mortality characteristics in Aids in France 1983-1990]. Rev Epidemiol Sante Publique [Internet]. 1992 [cited 2012 Jun 27];40(3):164–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1439058
Benhamou D, Lienhart A, Auroy Y, Péquignot F, Jougla E. Accidents by ABO incompatibility and other main complications related to blood transfusion in surgical patients: data from the French national survey on anaesthesia-related deaths. Transfus Clin Biol. 2005 Nov;12(5):389–90.
Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005 Feb;34(1):121–30.
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005 Jun;42(6):799–805.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37(6–7):482–7.
Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590–8.
Fouillet A, Rey G, Wagner V, Laaidi K, Empereur-Bissonnet P, Le Tertre A, et al. Has the impact of heat waves on mortality changed in France since the European heat wave of summer 2003? A study of the 2006 heat wave. Int J Epidemiol. 2008 Apr;37(2):309–17.
Kared H, Lelièvre JD, Donkova-Petrini V, Aouba A, Melica G, Balbo M, et al. HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. AIDS. 2008 Nov 30;22(18):2451–60.
Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol. 2008 Feb;48(2):200–7.
Ziadé N, Jougla E, Coste J. Population-level influence of rheumatoid arthritis on mortality and recent trends: a multiple cause-of-death analysis in France, 1970-2002. J Rheumatol. 2008 Oct;35(10):1950–7.
Romon I, Jougla E, Balkau B, Fagot-Campagna A. The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death. Eur J Epidemiol. 2008;23(5):327–34.
Carbonneil C, Donkova-Petrini V, Aouba A, Weiss L. Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses induced by dendritic cells generated in the presence of IFN-alpha. J Immunol. 2004 Jun 15;172(12):7832–40.
Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Peng J, Ménégoz F, Lesec’h JM, Remontet L, Grosclaude P, Buémi A, et al. [Larynx cancer in France: descriptive epidemiology and incidence estimation]. Bull Cancer. 2004 Apr;91(4):363–8.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.
Lienhart A, Auroy Y, Péquignot F, Benhamou D, Warszawski J, Bovet M, et al. [Preliminary results from the SFAR-iNSERM inquiry on anaesthesia-related deaths in France: mortality rates have fallen ten-fold over the past two decades]. Bull Acad Natl Med. 2004;188(8):1429–37; discussion 1437-1441.
Jougla E, Rican S, Péquignot F, Le Toullec A. [Socio-economic differences in mortality]. Rev Prat. 2004 Dec 31;54(20):2228–32.
Rey G, Jougla E. Are alcohol-attributable mortality estimates reliable? Eur J Public Health. 2014 Feb;24(1):3–4.
Lamarche-Vadel A, Pavillon G, Aouba A, Johansson LA, Meyer L, Jougla E, et al. Automated comparison of last hospital main diagnosis and underlying cause of death ICD10 codes, France, 2008-2009. BMC Med Inform Decis Mak. 2014;14:44.
Morlat P, Roussillon C, Henard S, Salmon D, Bonnet F, Cacoub P, et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS. 2014 May 15;28(8):1181–91.
Viallon V, Banerjee O, Jougla E, Rey G, Coste J. Empirical comparison study of approximate methods for structure selection in binary graphical models. Biom J. 2014 Mar;56(2):307–31.
Vuillermoz C, Aouba A, Grout L, Vandentorren S, Tassin F, Vazifeh L, et al. Estimating the number of homeless deaths in France, 2008-2010. BMC Public Health. 2014;14:690.
Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harlé JR, et al. Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis. Arthritis & Rheumatology [Internet]. 2014 Sep 1 [cited 2014 Oct 2];66(9):2503–1Available from: http://onlinelibrary.wiley.com.gate2.inist.fr/doi/10.1002/art.38731/abstract
Saucedo M, Bouvier-Colle MH, Chantry AA, Lamarche-Vadel A, Rey G, Deneux-Tharaux C. Pitfalls of national routine death statistics for maternal mortality study. Paediatr Perinat Epidemiol. 2014 Nov;28(6):479–88.
Lefeuvre D, Pavillon G, Aouba A, Lamarche-Vadel A, Fouillet A, Jougla E, et al. Quality comparison of electronic versus paper death certificates in France, 2010. Popul Health Metr. 2014;12(1):3.
Romon I, Rey G, Mandereau-Bruno L, Weill A, Jougla E, Eschwège E, et al. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort. Diabet Med. 2014 Aug;31(8):946–53.
Westerling R, Westin M, McKee M, Hoffmann R, Plug I, Rey G, et al. The timing of introduction of pharmaceutical innovations in seven European countries. J Eval Clin Pract. 2014 Aug;20(4):301–10.
Ecoffey C, Auroy Y, Pequignot F, Jougla E, Clergue F, Laxenaire MC, et al. A French survey of paediatric airway management use in tonsillectomy and appendicectomy. Paediatr Anaesth. 2003 Sep;13(7):584–8.